|
ADAM10 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.987100E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.458310E-02 |
| Normal-vs-Stage2 |
1.576370E-01 |
| Normal-vs-Stage3 |
9.838200E-02 |
| Normal-vs-Stage4 |
5.628400E-01 |
| Stage1-vs-Stage2 |
8.125200E-01 |
| Stage1-vs-Stage3 |
8.037600E-01 |
| Stage1-vs-Stage4 |
8.196600E-01 |
| Stage2-vs-Stage3 |
7.057000E-01 |
| Stage2-vs-Stage4 |
9.120000E-01 |
| Stage3-vs-Stage4 |
7.202800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.842470E-03 |
| Normal-vs-AfricanAmerican |
2.814100E-02 |
| Normal-vs-Asian |
9.292800E-01 |
| Caucasian-vs-AfricanAmerican |
7.172000E-01 |
| Caucasian-vs-Asian |
4.427900E-02 |
| AfricanAmerican-vs-Asian |
9.383700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.209730E-02 |
| Normal-vs-Female |
1.415660E-04 |
| Male-vs-Female |
1.616490E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.106800E-01 |
| Normal-vs-Extreme_Weight |
8.194000E-02 |
| Normal-vs-Obese |
3.198900E-03 |
| Normal-vs-Extreme_Obese |
7.345800E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.853400E-01 |
| Normal_Weight-vs-Obese |
1.655560E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.746200E-01 |
| Extreme_Weight-vs-Obese |
4.061600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.884200E-01 |
| Obese-vs-Extreme_Obese |
3.284200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.194630E-01 |
| Normal-vs-Age(41-60Yrs) |
8.15570000000099E-05 |
| Normal-vs-Age(61-80Yrs) |
6.128500E-02 |
| Normal-vs-Age(81-100Yrs) |
5.544600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.965400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.647400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.058840E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.719770E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.316800E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.354600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.360700E-04 |
| Normal-VS-Type2 PRCC |
8.516400E-01 |
| Normal-VS-KIRP CIMP |
3.089900E-02 |
| Normal-VS-Unclassified PRCC |
7.121100E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.197600E-04 |
| Type1 PRCC-VS-KIRP CIMP |
4.299800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.667600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.975700E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
6.102200E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
8.162800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.000200E-01 |
| Normal-vs-N1 |
5.922300E-02 |
| Normal-vs-N2 |
6.665200E-01 |
| N0-vs-N1 |
5.975800E-02 |
| N0-vs-N2 |
6.531400E-01 |
| N1-vs-N2 |
8.443200E-01 |
|
|
